Navigation Links
Living longer: Colon cancer patients gain time with radiofrequency ablation treatment

TAMPA, Fla. (March 16, 2010)Approximately half of Americans living with colorectal cancer will develop liver metastases at some point during the course of their disease. Radiofrequency ablation, a minimally invasive treatment that applies heat directly in the tumor causing cancer cell death with minimal associated injury to the surrounding healthy liver, contributes to prolongation of their life by nearly three years, note researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

"Patients who have recurrent colon cancer in their liver after surgery can be treated with radiofrequency ablation, or RFA, and avoid repeated liver surgery," said Constantinos T. Sofocleous, M.D., Ph.D., FSIR, an interventional radiologist at Memorial Sloan-Kettering Cancer Center in New York, N.Y. "RFA kills target cancer tissue with heat, while sparing the healthy tissue. This is particularly important for patients who develop new colon cancer in the liver after prior surgery. In general, these patients have a smaller amount of liver tissue; another surgery is usually not possible or very difficult and associated with higher risk," added Sofocleous, an associate professor of radiology at Weill Cornell Medical College, New York, N.Y. "This research shows how interventional radiologists can treat patients who have failed a prior surgical treatment. In addition it demonstrates how the combination of all available treatment modalities and the cooperation of medical specialists can improve the outcomes and may prolong patients' lives," he explained.

Colon cancer is the second leading cause of cancer-related death in the United States, with almost 150,000 new patients diagnosed each year, said Sofocleous. Approximately half of these patients will develop liver metastases at some point during the course of their disease; the majority of the patients are not candidates for surgery. "In those who undergo surgery, recurrence is a serious problem. Traditionally chemotherapy has been the only therapy. Radiofrequency ablation is a treatment that can destroy the tumor locally in the liver andin combination with systemic and local hepatic arterial chemotherapyit may extend the life of selected patients," he added.

"While the study did not make any direct comparisons to other treatments, survival rates after RFA were comparable to those of surgery," said Sofocleous. "We treated 56 patientsa highly selective population who had multiple prior treatments with surgery, systemic and local chemotherapyusing computed tomography- (CT) guided RFAover a six-year period and had survival rates of 91 percent at one year, 66 percent at two years and 41 percent at three years," said Sofocleous. More importantly, these survival ratesor life extensionsare in addition to the patients' survival rates after surgery," added the co-author of "Radiofrequency Ablation of Recurrent Colorectal Cancer Hepatic Metastases After Hepatectomy."

Radiofrequency ablation can be performed without affecting a patient's overall health, and most people can be discharged from the hospital within 24 hours and resume their usual activities in a few days. In this treatment, an interventional radiologist uses imaging to guide a needle through the skin into the tumor. The needle deposits radiofrequency energy into the target tissue, where it produces heat and kills the cancerous cells, sparing healthy tissue.

Medical records and relevant imaging were reviewed to determine technical success, complications and local tumor progression. Average tumor size was 1.9 centimeters, with average overall survival rate being 31 months. A modified clinical risk score was used to analyze the correlation with survival and local tumor progression according to nodal status of the primary cancer, interval from primary to liver metastases, number of tumors and size of the largest tumor ablated. Patients and tumor characteristics with having two or less of these risks factors had the best outcomes. Researchers also evaluated the influence of hepatic artery infusion (pump) chemotherapy on local disease and overall survival.


Contact: Maryann Verrillo
Society of Interventional Radiology

Related biology technology :

1. Touch Bionics acquires LIVINGSKIN
2. UCB Scholarship Program Awards $300,000 to Students Living with Crohns Disease
3. diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
4. Living Proof, Inc.: The Launch of the Next Beauty Revolution
5. Using living cells as nanotechnology factories
6. Imaging in Living Color with Siemens Molecular CT
7. Researchers develop new way to see single RNA molecules inside living cells
8. Genomas and Institute of Living Among Organizers of Pharmacogenetics Symposium at 2009 Annual Meeting of the American Psychiatric Association
9. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
10. As Predicted: Chronic Virus Found Living in Tumors of the Prostate
11. UCBs Cimzia(R) (certolizumab pegol), Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid Arthritis
Post Your Comments:
(Date:12/1/2015)... Bioscience, a company focused on synthetic DNA, today announced that ... as one of Foreign Policy,s 100 Leading Global ... life . Each year, Foreign Policy selects the ... changed lives and are shaping the world. ... be recognized among these incredible global leaders," said Leproust. "At ...
(Date:12/1/2015)... Calif. , Dec. 1, 2015 ... Transformational Health program. This program addresses ways companies ... of change. ... Logo - ... aspect of healthcare, as well as the disrupting ...
(Date:12/1/2015)... -- Oxford Finance LLC ("Oxford"), a specialty finance firm ... services companies, today announced the closing of a $3 ... Company"). Proceeds from the loan are being used for ... and daily skincare products. --> ... high potency skincare products that contain the proprietary and ...
(Date:12/1/2015)... Dec. 1, 2015  The Minnesota High Tech Association ... 2015 Tekne Award in the Small and Growing Healthcare ... Minneapolis Convention Center, the Tekne ... significant role in developing new technologies that positively impact ... world. Clostridium difficile infection ( C. ...
Breaking Biology Technology:
(Date:12/1/2015)... , Dec. 1, 2015 Synaptics Incorporated ... interface solutions, today announced a new agreement with ... with real-world test and development environments that combine FIDO ... The partnership reduces the complexity of FIDO certification for ... permits Synaptics and OEMs to verify FIDO enabled devices ...
(Date:11/30/2015)... , Nov. 30, 2015  BIOCLAIM announced today ... this year,s Fierce Innovation Awards:  Healthcare Edition, an ... , FierceHealthcare , ... a finalist in the category of "Privacy and ... --> Photo ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 Research ... of the "Capacitive Fingerprint Sensors - Technology and ... --> --> ... market, especially in smartphones. The fingerprint sensor vendor Idex ... fingerprint sensor units in mobile devices and of the ...
Breaking Biology News(10 mins):